BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11988079)

  • 1. Isolation and characterization of a polymerized prion protein.
    Lu BY; Chang JY
    Biochem J; 2002 May; 364(Pt 1):81-7. PubMed ID: 11988079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative folding of murine prion mPrP(23-231).
    Lu BY; Beck PJ; Chang JY
    Eur J Biochem; 2001 Jul; 268(13):3767-73. PubMed ID: 11432744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of isoforms of mouse prion protein with PrP(SC)-like structural properties.
    Lu BY; Chang JY
    Biochemistry; 2001 Nov; 40(44):13390-6. PubMed ID: 11683649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3-disulfide mutant of mouse prion protein expression, oxidative folding, reductive unfolding, conformational stability, aggregation and isomerization.
    Lu BY; Chang JY
    Arch Biochem Biophys; 2007 Apr; 460(1):75-84. PubMed ID: 17320038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible aggregation of mouse prion protein derivatives with PrPSC-like structural properties.
    Lu BY; Atanasov I; Zhou ZH; Chang JY
    J Protein Chem; 2003 Feb; 22(2):115-26. PubMed ID: 12760416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature.
    Martins SM; Chapeaurouge A; Ferreira ST
    J Biol Chem; 2003 Dec; 278(50):50449-55. PubMed ID: 14525996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
    Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
    Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization.
    Hornemann S; Korth C; Oesch B; Riek R; Wider G; Wüthrich K; Glockshuber R
    FEBS Lett; 1997 Aug; 413(2):277-81. PubMed ID: 9280297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway complexity of prion protein assembly into amyloid.
    Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
    J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmolyte trimethylamine N-oxide converts recombinant alpha-helical prion protein to its soluble beta-structured form at high temperature.
    Nandi PK; Bera A; Sizaret PY
    J Mol Biol; 2006 Sep; 362(4):810-20. PubMed ID: 16949096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126.
    Chatterjee B; Lee CY; Lin C; Chen EH; Huang CL; Yang CC; Chen RP
    PLoS One; 2013; 8(7):e67967. PubMed ID: 23844138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.
    Morillas M; Vanik DL; Surewicz WK
    Biochemistry; 2001 Jun; 40(23):6982-7. PubMed ID: 11389614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates.
    Wildegger G; Liemann S; Glockshuber R
    Nat Struct Biol; 1999 Jun; 6(6):550-3. PubMed ID: 10360358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability and conformational properties of doppel, a prion-like protein, and its single-disulphide mutant.
    Whyte SM; Sylvester ID; Martin SR; Gill AC; Wopfner F; Schätzl HM; Dodson GG; Bayley PM
    Biochem J; 2003 Jul; 373(Pt 2):485-94. PubMed ID: 12665426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR characterization of the pH 4 beta-intermediate of the prion protein: the N-terminal half of the protein remains unstructured and retains a high degree of flexibility.
    O'Sullivan DB; Jones CE; Abdelraheim SR; Thompsett AR; Brazier MW; Toms H; Brown DR; Viles JH
    Biochem J; 2007 Jan; 401(2):533-40. PubMed ID: 16958619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein mPrP[F175A](121-231): structure and stability in solution.
    Christen B; Hornemann S; Damberger FF; Wüthrich K
    J Mol Biol; 2012 Nov; 423(4):496-502. PubMed ID: 22922482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scrapie-infected cells, isolated prions, and recombinant prion protein: a comparative study.
    Kneipp J; Miller LM; Spassov S; Sokolowski F; Lasch P; Beekes M; Naumann D
    Biopolymers; 2004 May-Jun 5; 74(1-2):163-7. PubMed ID: 15137116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold destabilization and temperature jump of the murine prion protein mPrP(23-231).
    Matsumoto T; Nakagawa T; Kuwata K
    Biochim Biophys Acta; 2009 Apr; 1794(4):669-73. PubMed ID: 19336039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
    Yamaguchi K; Matsumoto T; Kuwata K
    Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.